Episode
Functional Precision Oncology, a new compass for cancer care | Apricot Bio
- Podcast
- Nucleate Podcast
- Published
- Dec 20, 2025
- Duration seconds
- 4980
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/functional-precision-oncology-a-new-compass-for-cancer-care-apricot-bio/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/nucleate-podcast-6322042/functional-precision-oncology-a-new-compass-for-cancer-care-apricot-bio.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this special panel episode recorded in Zurich, the founders of Apricot Bio, Michael Zering (CEO), Lucas Pelkmans (Scientific Founder), and Independent Professor Andreas Wicki from the University of Zurich explore the new field of functional precision oncology—an approach that goes beyond genomics to test how living cancer cells actually respond to treatment. The conversation covers the limits of genetic diagnostics, the promise of ex vivo drug testing, AI-driven decision-making, and how smarter trial design could transform cancer care. The panel also dives into Switzerland’s biotech ecosystem, venture capital realities, and what it takes to bring high-risk, high-impact science from the lab to the clinic.